Chen Jun, Gao Yunfei, Yang Yueying, Chu Jianhu, Li Xiaogang, Luo Dongbo
Department of Thoracic Surgery II, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi, China.
Department of Thoracic Surgery, People's Hospital of Bayin Guoleng Mongol Autonomous Prefecture, Korla, Xinjiang, China.
Ann Thorac Med. 2025 Apr-Jun;20(2):125-133. doi: 10.4103/atm.atm_236_24. Epub 2025 Mar 31.
To evaluate the perioperative outcomes of hybrid multi-arm robotic-assisted uniportal thoracoscopic surgery (H-URATS) using a laparoscopic stapling device, assess the safety and feasibility of the procedure, and summarize the surgical experience.
The Department of Thoracic Surgery at Xinjiang Tumor Hospital has performed over 100 H-URATS procedures using endoscopic staplers and the robotic surgery platform. We collected the clinical data and perioperative outcomes from patients undergoing Uniportal Video-assisted Thoracoscopic Surgery (UVATS) and H-URATS between January 2023 and August 2024. Propensity score matching (PSM) was conducted based on clinical characteristics and perioperative outcomes were compared between the two groups after matching.
A total of 395 patients were included, with 109 in the H-URATS group and 286 in the UVATS group. After PSM, each group consisted of 92 patients. There were no significant differences between the H-URATS and UVATS groups in terms of chest drainage duration, postoperative hospital stay, conversion to thoracotomy rate, intensive care unit admission rate, postoperative complication rate, postoperative pathological types, or tumor TNM staging ( > 0.05). The H-URATS group had less intraoperative blood loss compared to the UVATS group ( < 0.001), and more lymph nodes (LNs) and LN stations were dissected in the H-URATS group ( < 0.001).
In terms of short-term results, our study confirms the safety and feasibility of H-URATS as a new minimally invasive technique. It combines the advantages of uniportal thoracoscopy and robotic surgery systems and demonstrates potential benefits in oncological outcomes and complex procedures such as segmentectomies.
评估使用腹腔镜吻合器的杂交多臂机器人辅助单孔胸腔镜手术(H-URATS)的围手术期结果,评估该手术的安全性和可行性,并总结手术经验。
新疆肿瘤医院胸外科使用内镜吻合器和机器人手术平台进行了100余例H-URATS手术。我们收集了2023年1月至2024年8月期间接受单孔电视辅助胸腔镜手术(UVATS)和H-URATS患者的临床数据和围手术期结果。基于临床特征进行倾向评分匹配(PSM),匹配后比较两组的围手术期结果。
共纳入395例患者,H-URATS组109例,UVATS组286例。PSM后,每组各有92例患者。H-URATS组和UVATS组在胸腔引流时间、术后住院时间、中转开胸率、重症监护病房入住率、术后并发症发生率、术后病理类型或肿瘤TNM分期方面无显著差异(P>0.05)。与UVATS组相比,H-URATS组术中出血量更少(P<0.001),且H-URATS组清扫的淋巴结(LNs)和淋巴结站更多(P<0.001)。
就短期结果而言,我们的研究证实了H-URATS作为一种新的微创技术的安全性和可行性。它结合了单孔胸腔镜和机器人手术系统的优点,并在肿瘤学结果和诸如肺段切除术等复杂手术中显示出潜在益处。